Table 5 Baseline cost effectiveness results
From: Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania
Strategy | Cost | Incremental cost | DALYs Averted | Incremental DALYs | ICER |
|---|---|---|---|---|---|
Discounted | Â | Â | Â | Â | Â |
No Intervention | 0.0 | 0.0 | 0.00 | 0.00 | 0 |
Rotavirus Vaccine Alone | 59.3 | 59.3 | 1.39 | 1.39 | 43 |
Diarrhoea Management | 112.2 | 52.9 | 1.98 | 0.59 | 90 |
Rotavirus V& Diarrhoea Management | 166.7 | 54.5 | 2.47 | 0.49 | 112 |